GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EuBiologics Co Ltd (XKRX:206650) » Definitions » Loans Receivable

EuBiologics Co (XKRX:206650) Loans Receivable : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is EuBiologics Co Loans Receivable?

EuBiologics Co's Loans Receivable for the quarter that ended in Dec. 2024 was ₩0 Mil.


EuBiologics Co Loans Receivable Historical Data

The historical data trend for EuBiologics Co's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EuBiologics Co Loans Receivable Chart

EuBiologics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

EuBiologics Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

EuBiologics Co Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


EuBiologics Co Loans Receivable Related Terms

Thank you for viewing the detailed overview of EuBiologics Co's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


EuBiologics Co Business Description

Traded in Other Exchanges
N/A
Address
6F Bomnal-A-Chim B/D Mabang-ro 8, Seocho-gu, Seoul, KOR, 06778
EuBiologics Co Ltd is a biopharmaceutical company, which develops and supplies vaccines for epidemics and antibiotic resistance in South Korea. It offers Euvchol, an oral cholera prevention vaccine; and CRM197, a diphtheria toxin mutant vaccine, Inaba Cairo, and among others.

EuBiologics Co Headlines

No Headlines